Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a -2.585% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) Cc1ccc(C23CC4CC(CC(NC(=O)NCCN(C)C)(C4)C2)C3)cc1
b) COc1ccc(C2(c3ccc(OC)cc3)NC(=O)N(CC(=O)NC(C)C)C2=O)cc1
Answer: b. COc1ccc(C2(c3ccc(OC)cc3)NC(=O)N(CC(=O)NC(C)C)C2=O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(C2(c3ccc(OC)cc3)NC(=O)N(CC(=O)NC(C)C)C2=O)cc1
COc1ccc(C2(c3ccc(OC)cc3)NC(=O)N(CC(=O)NC(C)C)C2=O)cc1
2-[4,4-bis(4-methoxyphenyl)-2,5-dioxoimidazolidin-1-yl]-N-propan-2-ylacetamide